Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ONCCVE:SNG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeONCBeOne Medicines$241.20-5.2%$247.90$141.84▼$287.88$26.44B0.3340,472 shs400,801 shsSNGSilver Range ResourcesC$0.10+11.1%C$0.09C$0.06▼C$0.14C$9.81M-0.0227,143 shs51,200 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceONCBeOne Medicines0.00%-2.38%-1.97%-11.38%+24,119,999,900.00%SNGSilver Range Resources0.00%0.00%+17.65%+11.11%+25.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationONCBeOne Medicines3.4605 of 5 stars4.50.00.00.03.01.70.6SNGSilver Range ResourcesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceONCBeOne Medicines 3.00Buy$320.6732.95% UpsideSNGSilver Range Resources 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HEMO, ONC, OBD, and SNG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/27/2025ONCBeOne MedicinesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$313.00 ➝ $330.006/27/2025ONCBeOne MedicinesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$317.00 ➝ $321.006/27/2025ONCBeOne MedicinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Moderate Buy$311.005/8/2025ONCBeOne MedicinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$312.00 ➝ $311.005/8/2025ONCBeOne MedicinesGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$348.00 ➝ $350.004/28/2025ONCBeOne MedicinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$312.00 ➝ $312.004/24/2025ONCBeOne MedicinesTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$334.00 ➝ $334.004/21/2025ONCBeOne MedicinesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$311.00 ➝ $317.004/16/2025ONCBeOne MedicinesGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/10/2025ONCBeOne MedicinesGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$348.00 ➝ $348.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookONCBeOne Medicines$3.81B6.94N/AN/A$34.10 per share7.07SNGSilver Range ResourcesN/AN/AC$0.01 per share16.25C$0.10 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateONCBeOne Medicines-$644.79M-$3.72N/A339.72N/A-9.40%-7.55%-4.42%N/ASNGSilver Range Resources-C$1.04M-C$0.01N/A∞N/AN/A-9.79%-5.12%N/ALatest HEMO, ONC, OBD, and SNG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025ONCBeOne Medicines-$0.71$1.22+$1.93$0.01$1.12 billion$1.12 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthONCBeOne MedicinesN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioONCBeOne Medicines0.051.961.71SNGSilver Range Resources0.070.947.93Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipONCBeOne Medicines48.55%SNGSilver Range ResourcesN/AInsider OwnershipCompanyInsider OwnershipONCBeOne Medicines6.62%SNGSilver Range Resources37.11%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableONCBeOne Medicines11,000109.60 million102.34 millionN/ASNGSilver Range ResourcesN/A98.13 millionN/ANot OptionableHEMO, ONC, OBD, and SNG HeadlinesRecent News About These CompaniesWalker Lane Resources Options Three Properties in the Walker Lane Gold Trend in Nevada from Silver Range ResourcesMarch 26, 2025 | juniorminingnetwork.comSilver Range Resources Ltd. Announces a Shareholder Holding In Excess of 10% of Its Currently Issued Share CapitalJanuary 27, 2025 | goldseiten.deThe Forage, the Ausdance ACT Youth Dance Festival, SpringOUT and more: 50 ways to fill your first week of NovemberNovember 5, 2024 | hercanberra.com.auHIndustry Pro Newsletter: Theater Educators Face Growing Censorship Challenges, Says EdTANovember 5, 2024 | broadwayworld.com300+ Amazon Prime Day deals still live: Roomba, Apple, Dyson, and other top brandsOctober 11, 2024 | msn.com300+ Amazon Prime Day deals: Just a few hours left to shop Roomba, Apple, Dyson, and other top brandsOctober 11, 2024 | yahoo.comHappenings around the Perham area, Oct. 10-20October 11, 2024 | perhamfocus.comPObituary: Raymond Moskow, 92, Longtime Wilton Resident, Community Leader and Tireless VolunteerOctober 11, 2024 | goodmorningwilton.comGPandion Music Foundation Announces Free Music Industry Programs For OctoberOctober 11, 2024 | musicconnection.comMPRS gives its SE range a huge overhaul, introduces the long-awaited lefty John Mayer Silver SkyOctober 9, 2024 | msn.comSNG:CA Silver Range Resources Ltd.October 3, 2024 | seekingalpha.comOsceola County things to do, starting Oct. 4October 2, 2024 | yahoo.comMore ore-grade silver with a dash of lead at Maronan’s namesake projectSeptember 26, 2024 | stockhead.com.auSStage: Fall Arts Preview 2024September 24, 2024 | metroweekly.comMHappenings around the Perham area, Sept. 19-29September 21, 2024 | perhamfocus.comPKansas City Silver: Local Retro, Labor Fight & Old-School Tech BlowupSeptember 19, 2024 | tonyskansascity.comTWe've Found the Best Face Washes for Dry Skin That Won't Strip Your SkinSeptember 18, 2024 | msn.com1981 Ferrari Mondial 8: The Legend Always LurksAugust 18, 2024 | caranddriver.comCGauss Labs Releases AI-Based Virtual Metrology Solution, Panoptes VM 2.0August 12, 2024 | koreaherald.comKEagle Royalties Acquires East Goldfield Royalty in Nevada, Issues Incentive OptionsAugust 8, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?Analysts Are Bullish on Marvell Stock Despite Amazon Deal ConcernBy Leo Miller | June 2, 2025View Analysts Are Bullish on Marvell Stock Despite Amazon Deal ConcernPalantir Soars on Government Deals as Valuation Debate LingersBy Chris Markoch | June 3, 2025View Palantir Soars on Government Deals as Valuation Debate LingersWant AI Exposure? These 3 ETFs Offer Different AnglesBy Chris Markoch | June 9, 2025View Want AI Exposure? These 3 ETFs Offer Different AnglesMarketBeat Week in Review – 05/26 - 05/30By MarketBeat Staff | May 31, 2025View MarketBeat Week in Review – 05/26 - 05/30HEMO, ONC, OBD, and SNG Company DescriptionsBeOne Medicines NASDAQ:ONC$241.20 -13.29 (-5.22%) As of 06/27/2025 04:00 PM EasternBeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.Silver Range Resources CVE:SNGC$0.10 +0.01 (+11.11%) As of 06/27/2025 03:46 PM EasternSilver Range Resources Ltd., a junior resource exploration company, engages in the acquisition, exploration, and evaluation of precious metal resources in Canada. The company explores for gold, silver, zinc, lead, and copper deposits. Its property portfolio comprises mineral properties located in Nevada, the Northwest Territories, Nunavut, and the Yukon Territory. Silver Range Resources Ltd. was incorporated in 2010 and is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
